Blog

• posted: May 01, 2023

Good news for patients suffering from Chronic Migraine or new daily persistent headache.  A retrospective review of 77 patients who underwent administration of intravenous, subanesthetic ketamine was conducted by investigators Read More

• posted: May 01, 2023

Complex Regional Pain Syndrome (CRPS) is an extremely painful neuropathic pain condition that is notoriously hard to treat. At present, there are no FDA-approved medications that are indicated for treating Read More

• posted: May 01, 2023

Depression affects approximately one in five Americans and while most people respond to antidepressant medications, 1/3 will not. However, emerging research and countless case studies have shown that intravenous (IV) Read More

• posted: May 01, 2023

Ticks have arguably the most dangerous bite to humans of any species. Our warming climate will only make things worse as ticks become able to breed all year long, and Read More

• posted: May 01, 2023

Ketamine is a long known anesthetic agent that is still used for induction anesthesia in medicine today. It is also used off label for the treatment of various treatment-resistant diseases Read More

• posted: May 01, 2023

A clinical study conducted by researchers at the Leiden University Medical Center in The Netherlands evaluated the efficacy of a multi-day infusion regimen of intravenous ketamine for treating CRPS (Chronic Read More

• posted: May 01, 2023

For patients who respond poorly or incompletely to opioids, ketamine may be the answer. In the middle of the past century, phencyclidine hydrochloride—called PCP or angel dust on the street—was Read More

• posted: May 01, 2023

IV Ketamine has shown to be rapidly effective in treating PTSD in a recent study conducted by Emory University. In the first day after treatment, mean scores on the Impact of Read More

• posted: May 01, 2023

Lianne Milton/For NPR Chris Stephens, 28, has been battling depression all of his life. At times he wouldn’t get out of bed for weeks. In January, he said his depression hadn’t Read More

• posted: May 01, 2023

First randomized clinical trial shows efficacy of intravenous ketamine for treating Posttraumatic Stress Disorder  A team of researchers put intravenous (IV) ketamine therapy to the test in forty-one patients with chronic Read More

• posted: May 01, 2023

One of Americans’ most common medical complaints is chronic pain. According to Institute of Medicine of The National Academies, over 100 million Americans suffer from chronic pain. Furthermore, it is Read More

• posted: May 01, 2023

Ketamine has long been used as an anesthetic in both adults and children for more than 50 years. Although it is still used for anesthesia and also off-label for the Read More

• posted: May 01, 2023

Fibromyalgia Syndrome: Your Questions Answered  Fibromyalgia syndrome is a common and chronic disorder characterized by widespread pain, diffuse tenderness and many other symptoms. So what do sufferers really need to know? Read More

• posted: May 01, 2023

Ketamine, a long known anesthetic drug, has recently experienced resurgence in use due to the serendipitous discovery of new activities. These new activities have afforded new treatment options for notoriously Read More